FineHeart Receives ANSM1 Authorization to Deploy Its First-In-Human Clinical Study in France
/
DateJun 03 2025
Patients with advanced heart failure will be treated with FlowMaker®, an innovative, fully implantable device for restoring cardiac output. BORDEAUX, France–(BUSINESS WIRE)–FineHeart S.A., a clinical-stage... Read More →